Latest publications

AbstractBACKGROUND:Recurrence patterns in stage III colon cancer (CC) patients according to molecular markers remain...

Posted by : Dr. Dewi VERNEREY,
Journal name : Ann Surg Oncol.

AbstractBackgroundNivolumab-ipilimumab demonstrated a survival benefit over sunitinib in first-line setting for...

Posted by : ,
Journal name : European Journal of Cancer